Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies in Leukemias: Independent Conference Coverage of ASH 2020
  • CME

Jorge Cortes, MD
Eunice S. Wang, MD
Released: February 12, 2021
Back Next

Introduction

At the virtual ASH 2020 annual meeting, new clinical data were reported in the settings of acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic leukemia (ALL). In this expert analysis module, Jorge Cortes, MD, and Eunice S. Wang, MD, review and discuss the clinical implications of key findings for these diseases that were presented at the meeting.

Please note that the slide thumbnails embedded in this activity link to short PowerPoint slidesets, each focused on the specific study of interest. The slides for the studies covered in this activity may be downloaded by clicking on any of the thumbnails within the activity.

CCO plans to measure the educational impact of this activity. Some of the questions in this activity will be asked twice: once at the beginning and then once again after the specific discussion of the relevant information. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
AstraZeneca
Bristol-Myers Squibb
Epizyme Inc.
GlaxoSmithKline
Incyte Corporation
Janssen Biotech
Karyopharm Therapeutics Inc.
Novartis
PharmaEssentia Corp.
Seattle Genetics
Takeda Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue